These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 12579302

  • 1. Novel cell culture models for prevention of human breast cancer (Review).
    Katdare M, Osborne MP, Telang NT.
    Int J Oncol; 2003 Mar; 22(3):509-15. PubMed ID: 12579302
    [Abstract] [Full Text] [Related]

  • 2. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N, Katdare M.
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [Abstract] [Full Text] [Related]

  • 3. Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials.
    Scott EN, Gescher AJ, Steward WP, Brown K.
    Cancer Prev Res (Phila); 2009 Jun; 2(6):525-30. PubMed ID: 19470784
    [Abstract] [Full Text] [Related]

  • 4. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.
    Fenton JI, Hord NG.
    Carcinogenesis; 2006 May; 27(5):893-902. PubMed ID: 16474168
    [Abstract] [Full Text] [Related]

  • 5. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

  • 6. Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression.
    Li Z, Meng ZH, Sayeed A, Shalaby R, Ljung BM, Dairkee SH.
    Cancer Res; 2002 Oct 15; 62(20):5980-7. PubMed ID: 12384566
    [Abstract] [Full Text] [Related]

  • 7. Prevention of early-onset familial/hereditary colon cancer: new models and mechanistic biomarkers (review).
    Telang NT, Li G, Katdare M.
    Int J Oncol; 2006 Jun 15; 28(6):1523-9. PubMed ID: 16685453
    [Abstract] [Full Text] [Related]

  • 8. Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5.
    Hussain-Hakimjee EA, Peng X, Mehta RR, Mehta RG.
    Carcinogenesis; 2006 Mar 15; 27(3):551-9. PubMed ID: 16195238
    [Abstract] [Full Text] [Related]

  • 9. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.
    Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, van Spaendonk R, Wolman SR.
    Breast Cancer Res Treat; 2006 Mar 15; 96(2):177-86. PubMed ID: 16319984
    [Abstract] [Full Text] [Related]

  • 10. Tissue culture as a hostile environment: identifying conditions for breast cancer progression studies.
    Shay JW, Wright WE.
    Cancer Cell; 2007 Aug 15; 12(2):100-1. PubMed ID: 17692800
    [Abstract] [Full Text] [Related]

  • 11. In search of a stem cell hierarchy in the human breast and its relevance to breast cancer evolution.
    Villadsen R.
    APMIS; 2005 Aug 15; 113(11-12):903-21. PubMed ID: 16480457
    [Abstract] [Full Text] [Related]

  • 12. Isogenic normal basal and luminal mammary epithelial isolated by a novel method show a differential response to ionizing radiation.
    Huper G, Marks JR.
    Cancer Res; 2007 Apr 01; 67(7):2990-3001. PubMed ID: 17409405
    [Abstract] [Full Text] [Related]

  • 13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 14. Alterations in the expression of PDCD4 in ductal carcinoma of the breast.
    Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O.
    Oncol Rep; 2007 Dec 01; 18(6):1387-93. PubMed ID: 17982621
    [Abstract] [Full Text] [Related]

  • 15. A peroxisome proliferator-activated receptor-gamma agonist and the p53 rescue drug CP-31398 inhibit the spontaneous immortalization of breast epithelial cells.
    Herbert BS, Pearce VP, Hynan LS, LaRue DM, Wright WE, Kopelovich L, Shay JW.
    Cancer Res; 2003 Apr 15; 63(8):1914-9. PubMed ID: 12702583
    [Abstract] [Full Text] [Related]

  • 16. Breast differentiation and its implication in cancer prevention.
    Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 2):931s-6s. PubMed ID: 15701889
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis induction by sulfur-containing compounds in malignant and nonmalignant human cells.
    Fimognari C, Lenzi M, Hrelia P.
    Environ Mol Mutagen; 2009 Apr 15; 50(3):171-89. PubMed ID: 19170195
    [Abstract] [Full Text] [Related]

  • 18. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
    Trost TM, Lausch EU, Fees SA, Schmitt S, Enklaar T, Reutzel D, Brixel LR, Schmidtke P, Maringer M, Schiffer IB, Heimerdinger CK, Hengstler JG, Fritz G, Bockamp EO, Prawitt D, Zabel BU, Spangenberg C.
    Cancer Res; 2005 Feb 01; 65(3):840-9. PubMed ID: 15705882
    [Abstract] [Full Text] [Related]

  • 19. High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.
    Rennstam K, Hedenfalk I.
    Breast Cancer Res; 2006 Feb 01; 8(4):213. PubMed ID: 16895590
    [Abstract] [Full Text] [Related]

  • 20. Prostate cancer chemoprevention by silibinin: bench to bedside.
    Singh RP, Agarwal R.
    Mol Carcinog; 2006 Jun 01; 45(6):436-42. PubMed ID: 16637061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.